IMC Chicago
ALXN

IMC Chicago’s Alexion Pharmaceuticals ALXN Stock Holding History

IMC Chicago’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-45,400
Closed -$7.09M – 1224
2020
Q4 		$7.09M Buy
+45,400
New +$5.83M 0.01% 476
2020
Q2 		– Sell
-11,800
Closed -$1.06M – 980
2020
Q1 		$1.06M Buy
11,800
+200
+2% +$19.6K ﹤0.01% 624
2019
Q4 		$1.25M Sell
11,600
-8,600
-43% -$920K ﹤0.01% 601
2019
Q3 		$1.98M Buy
20,200
+9,400
+87% +$1.06M 0.01% 462
2019
Q2 		$1.42M Sell
10,800
-12,000
-53% -$1.55M ﹤0.01% 484
2019
Q1 		$3.08M Buy
22,800
+7,900
+53% +$982K 0.01% 307
2018
Q4 		$1.45M Buy
+14,900
New +$1.76M ﹤0.01% 394

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return